ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

LMNL Liminal BioSciences Inc

8.50
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Liminal BioSciences Inc LMNL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 8.50 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/10/202307:30EDGAR2Form 15-12G - Securities registration termination [Section..
27/9/202315:05EDGAR2Form SC 13D/A - General statement of acquisition of..
26/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
26/9/202308:12EDGAR2Form POS AM - Post-Effective amendments for registration..
26/9/202308:08EDGAR2Form 25-NSE - Notification filed by national security..
26/9/202307:57EDGAR2Form S-8 POS - Securities to be offered to employees in..
26/9/202307:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202307:54EDGAR2Form SC 13E3/A - Going private transaction by certain..
26/9/202307:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202307:00PRNUSLIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF..
19/9/202315:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202315:34PRNUSLIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF..
19/9/202315:22PRNCALIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF..
15/9/202311:03PRNUSLIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT..
15/9/202311:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/9/202310:29PRNUSLIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT..
12/9/202307:38EDGAR2Form SC 13E3/A - Going private transaction by certain..
12/9/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202307:02PRNUSLIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND..
12/9/202306:45PRNCALIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND..
16/8/202316:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/8/202316:20PRNUSLIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED..
16/8/202315:46PRNUSLIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED..
08/8/202315:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202315:05PRNUSLiminal BioSciences Reports Second Quarter Financial Results..
02/8/202315:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202306:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202306:30PRNUSLiminal BioSciences Announces Arrangement Agreement with..
05/6/202315:05PRNCALiminal BioSciences Announces Voting Results of its 2023..
02/6/202307:00PRNCALiminal BioSciences Provides R&D Update
09/5/202315:05PRNCALiminal BioSciences Reports First Quarter Financial Results..
08/5/202307:00PRNCAThe Special Committee of the Board of Directors of Liminal..

Su Consulta Reciente

Delayed Upgrade Clock